AbbVie Took Two EU Approvals in One Day, Both for Diseases Payers Have Called Cosmetic
The European Commission approved RINVOQ for non-segmental vitiligo and, the same day, for severe alopecia areata, both in adults and adolescents aged 12 and over.
The Beats
Analysis
The Briefs
AbbVie Took Two EU Approvals in One Day, Both for Diseases Payers Have Called Cosmetic
The Alzheimer’s Blood Test Just Moved Into the GP’s Office, Which Is the Whole Point
A Private Device Company Just Put Its Pivotal Trial Head to Head Against the Market Leader
Brazil Approved Five Semaglutides in a Day. Sandoz Announced One of Them.
NICE Said Yes to the Lung Machine, and Then Attached Four Years of Conditions